Munich Re’s 66.8% Combined Ratio and 57% Profit Jump Conceal a Deliberate Shrinkage Strategy

Despite record underwriting margins and strong capital, Munich Re’s stock falls 14% YTD as investors penalise its cautious renewal strategy and price discipline.

Munich Re delivered a near-flawless first quarter, but the equity market has reacted as if the insurer stumbled. Net profit surged 57% to €1.7 billion, underwriting margins hit exceptional levels, and capital remains plentiful. Yet the stock sits around €473, within touching distance of its 52-week low and 22% below the €605 peak touched just twelve months ago. The contradiction points to a deeper tension: the company is winning the profitability battle but losing the narrative war.

The headline numbers are hard to fault. The property-casualty reinsurance combined ratio came in at 66.8% – meaning Munich Re spent well under 67 cents for every premium euro earned on claims and expenses. Investment income contributed nearly €1 billion, while the life and health segment also performed solidly. ERGO, the primary insurance arm, kicked in €235 million to group earnings. Equity under IFRS rose to €34.6 billion, and the Solvency II ratio, though dipping from 298% to 292%, remains more than double the regulatory minimum.

That capital strength supports a generous shareholder return policy, but the market’s scepticism centres on what Munich Re is not doing. At the 1 April renewal season, the group deliberately shrank its new business by 18.5%. After adjusting for inflation and risk changes, prices actually fell 3.1% – a clear sign the company walked away from deals it considered inadequately priced. Chief Financial Officer Buchanan described the pricing level as “good” despite the decline, signalling a disciplined approach that prioritises margin over volume. Rival Hannover Rück took the opposite tack, expanding aggressively. Two industry leaders reading the same market data and drawing opposite conclusions.

Shareholders appear to be punishing that restraint. The stock is down roughly 14% year to date and has lost nearly 16% over the past 30 days. Even a mild uptick of 1% on the day of the Q1 release failed to reverse the mood. The relative strength index of 72 suggests the equity is technically overbought on shorter time frames – an odd condition given the sustained sell-off, and one that hints at a potential snap-back if sentiment shifts.

Meanwhile, Munich Re is reshaping its domestic cost base through ERGO. By 2030, roughly 1,000 positions will be eliminated in Germany, with repetitive tasks in phone handling, customer correspondence and claims processing targeted for automation. The group says it wants to avoid outright layoffs; up to 700 employees are expected to be retrained via an internal reskilling academy. More than 300 artificial-intelligence use cases are already running across the broader organisation.

The capital return programme is substantial. For 2025, Munich Re paid a dividend of €24.00 per share. A share buyback of up to €2.25 billion is under way, with the first €900 million tranche launched in mid-May and the entire programme scheduled to run until April 2027. At a price-to-earnings ratio of roughly 10, the valuation looks undemanding – provided earnings hold up.

For 2026, management is standing behind its group net profit target of €6.3 billion on combined insurance revenue of about €64 billion. Delivering that hinges on catastrophe losses staying within normal ranges; the current quarter’s results were helped by low natural disaster claims, though the conflict in the Persian Gulf added an estimated €90 million to the bill. The “Ambition 2030” strategic plan calls for average annual earnings-per-share growth above 8% and a payout ratio exceeding 80%.

The next key test comes with the July renewal season. Munich Re expects broadly stable pricing. If that forecast proves accurate, the main criticism – that the company is giving up top-line growth too readily – loses some of its weight. Between the buyback, the dividend and the sheer capital strength, the ingredients for a recovery are there. The market is waiting to see whether the pricing environment will let Munich Re deploy its capital advantage without sacrificing the underwriting quality it has so carefully rebuilt.